Dr. Chinweike Ukomadu

Board of Directors

Dr. Chinweike (Chinwe) Ukomadu is Head of the Gastrointestinal and Inflammation Therapeutic Area Unit at Takeda. The therapeutic area pipeline focuses on variety of GI programs as well as inflammatory and immunologic programs in dermatology, rheumatology and hematology. Under his leadership, Takeda expanded its drug development pipeline with treatments for inflammatory conditions and advanced the development of an antibody-based medicine for diseases involving the immune system. Under his leadership, Takeda has received several approvals from multiple health authorities, achieved several IND filings, and executed key partnership deals—all essential components of building a sustainable R&D pipeline focused on gastroenterology and immunology.

Chinwe joined Takeda from the Novartis Institutes for BioMedical Research (NIBR) where he was the head of the translational medicine Gastroenterology and Liver program. Prior to Novartis, Chinwe was an associate physician at Brigham and Women’s Hospital in Boston and an assistant professor of medicine at Harvard Medical School. In addition, Chinwe led a National Institutes of Health (NIH)-funded laboratory studying how the liver repairs and regenerates itself. He oversaw the Summer Training in Academic Research and Scholarship program for under-represented minority college students, taught in and directed a gastroenterology course for medical students at Harvard Medical School.

Chinwe received his M.D. and Ph.D. from the Yale University School of Medicine and was a resident and chief medical resident in internal medicine, as well as a fellow in gastroenterology at the Brigham and Women’s Hospital in Boston.